Compare KRYS & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | CGNX |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.7B |
| IPO Year | 2017 | 1994 |
| Metric | KRYS | CGNX |
|---|---|---|
| Price | $345.32 | $66.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $297.60 | $57.91 |
| AVG Volume (30 Days) | 242.1K | ★ 1.9M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | ★ 128.00 | 9.68 |
| EPS | ★ 1.83 | 0.31 |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $9.52 |
| Revenue Next Year | $32.53 | $8.63 |
| P/E Ratio | ★ $186.02 | $209.08 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $130.17 | $31.42 |
| 52 Week High | $347.67 | $71.90 |
| Indicator | KRYS | CGNX |
|---|---|---|
| Relative Strength Index (RSI) | 73.08 | 58.06 |
| Support Level | $253.89 | $59.00 |
| Resistance Level | N/A | $70.45 |
| Average True Range (ATR) | 12.58 | 2.66 |
| MACD | 3.13 | 0.01 |
| Stochastic Oscillator | 86.78 | 80.72 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.